Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and RIPC in Tetralogy of Fallot Surgery
NCT05691764Completed
- Sponsor
- Universitas Indonesia
- Start
- Sep 2020
- Primary completion
- Dec 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cyclosporine in myocardial reperfusion injury (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Malondialdehyde at 1 year, Calcium cytosol concentration at 1 year and 1 more. Started Sep 2020; status: completed.
02
Drugs
cyclosporine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT05691764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691764.